A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
This Annual Report on Form 10-K should be read together and in connection with the other reports that have been filed by us with the SEC for a comprehensive description of our financial condition and operating results. In the interest of disclosure, we have included in this Form 10-K certain material events and developments that have taken place through the date of filing of this Form 10-K with the SEC. In this Annual Report on Form 10-K, INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., (INVO Fertility, Inc., together with its subsidiaries, is referred to in this document as “we”, “us”, “INVO Fertility”, “INVO”, or the “Company”), incorporates by reference certain information from parts of other documents filed with the SEC. The SEC allows us to disclose important information by referring to it in that manner. Please refer to all such information when reading this Annual Report on Form 10-K. All information is as of December 31, 2024, unless otherwise indicated.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 6.9M | 6.5M | 3.0M | 822K | 4.2M | - |
| Net Income | -29M | - | - | - | -6.7M | -8.3M |
| EPS | $-394.88 | $-724.56 | $-1,616.88 | $-431.28 | $-15.12 | $-36.48 |
| Free Cash Flow | -7.8M | -3.2M | -5.2M | -6.6M | -6.4M | -4.8M |
| ROIC | -111.1% | - | - | - | -91.0% | -39.8% |
| Gross Margin | 39.2% | 43.1% | 34.7% | 59.7% | 96.5% | - |
| Debt/Equity | 0.31 | 0.09 | 3.10 | -0.78 | 0.02 | 0.03 |
| Dividends/Share | $0.00 | - | $0.00 | $0.00 | - | - |
| Operating Income | -9.8M | -8.1M | -6.8M | -11M | -5.2M | -5.5M |
| Operating Margin | -141.1% | -124.4% | -224.0% | -1292.5% | -125.4% | - |
| ROE | -499.4% | - | - | - | -102.0% | -822.6% |
| Shares Outstanding | 2M | 0M | 0M | 0M | 0M | 0M |
INVO Fertility, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 58.5%.
INVO Fertility, Inc. (IVF) has a 5-year average return on invested capital (ROIC) of -65.4%. This is below average and may indicate limited pricing power.
INVO Fertility, Inc. (IVF) has a market capitalization of $4M. It is classified as a small-cap stock.
INVO Fertility, Inc. (IVF) does not currently pay a regular dividend.
INVO Fertility, Inc. (IVF) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
INVO Fertility, Inc. (IVF) reported annual revenue of $7 million in its most recent fiscal year, based on SEC EDGAR filings.
INVO Fertility, Inc. (IVF) generated $-3 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
INVO Fertility, Inc. (IVF) has a debt-to-equity ratio of 0.09. This indicates a conservatively financed balance sheet.
INVO Fertility, Inc. (IVF) reported earnings per share (EPS) of $-724.56 in its most recent fiscal year.
INVO Fertility, Inc. (IVF) has a 5-year average gross margin of 58.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 14 years of financial data for INVO Fertility, Inc. (IVF), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
INVO Fertility, Inc. (IVF) has a book value per share of $820.17, based on its most recent annual SEC filing.
No recent press releases.